{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T03:02:00Z","timestamp":1792465320850,"version":"4.5.0"},"reference-count":67,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Best Practice &amp; Research Clinical Endocrinology &amp; Metabolism"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1016\/j.beem.2024.101958","type":"journal-article","created":{"date-parts":[[2024,11,26]],"date-time":"2024-11-26T03:03:45Z","timestamp":1732590225000},"page":"101958","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":23,"title":["Recent progress in the pathologic classification of pheochromocytomas and paragangliomas"],"prefix":"10.1016","volume":"38","author":[{"given":"Ozgur","family":"Mete","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C. Christofer","family":"Juhlin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.beem.2024.101958_bib1","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1007\/s12022-022-09704-6","article-title":"Overview of the 2022 WHO classification of paragangliomas and pheochromocytomas","volume":"33","author":"Mete","year":"2022","journal-title":"Endocr Pathol"},{"issue":"1","key":"10.1016\/j.beem.2024.101958_bib2","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1007\/s12022-022-09708-2","article-title":"Overview of the 2022 WHO classification of neuroendocrine neoplasms","volume":"33","author":"Rindi","year":"2022","journal-title":"Endocr Pathol"},{"issue":"1","key":"10.1016\/j.beem.2024.101958_bib3","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1007\/s12105-022-01435-8","article-title":"Update from the 5th Edition of the World Health Organization Classification of Head and Neck Tumors: overview of the 2022 WHO classification of head and neck neuroendocrine neoplasms","volume":"16","author":"Mete","year":"2022","journal-title":"Head Neck Pathol"},{"key":"10.1016\/j.beem.2024.101958_bib4","doi-asserted-by":"crossref","DOI":"10.1007\/s12022-024-09830-3","article-title":"The molecular classification of pheochromocytomas and paragangliomas: discovering the genomic and immune landscape of metastatic disease","author":"de Bresser","year":"2024","journal-title":"Endocr Pathol"},{"issue":"4","key":"10.1016\/j.beem.2024.101958_bib5","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.tem.2023.12.003","article-title":"A clinical perspective on ectopic Cushing's syndrome","volume":"35","author":"Ragnarsson","year":"2024","journal-title":"Trends Endocrinol Metab"},{"issue":"8","key":"10.1016\/j.beem.2024.101958_bib6","doi-asserted-by":"crossref","first-page":"e145","DOI":"10.4158\/EP14093.CR","article-title":"Malignant pheochromocytoma secreting vasoactive intestinal peptide and response to sunitinib: a case report and literature review","volume":"20","author":"Leibowitz-Amit","year":"2014","journal-title":"Endocr Pr"},{"issue":"9","key":"10.1016\/j.beem.2024.101958_bib7","doi-asserted-by":"crossref","first-page":"280","DOI":"10.3390\/jcm7090280","article-title":"The diagnosis and clinical significance of paragangliomas in unusual locations","volume":"7","author":"Asa","year":"2018","journal-title":"J Clin Med"},{"issue":"2","key":"10.1016\/j.beem.2024.101958_bib8","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1007\/s12022-021-09675-0","article-title":"Challenges in paragangliomas and pheochromocytomas: from histology to molecular immunohistochemistry","volume":"32","author":"Juhlin","year":"2021","journal-title":"Endocr Pathol"},{"issue":"1","key":"10.1016\/j.beem.2024.101958_bib9","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1038\/s41467-023-36769-6","article-title":"Genomic and immune landscape of metastatic pheochromocytoma and paraganglioma","volume":"14","author":"Calsina","year":"2023","journal-title":"Nat Commun"},{"issue":"2","key":"10.1016\/j.beem.2024.101958_bib10","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.ccell.2017.01.001","article-title":"Comprehensive molecular characterization of pheochromocytoma and paraganglioma","volume":"31","author":"Fishbein","year":"2017","journal-title":"Cancer Cell"},{"issue":"1","key":"10.1016\/j.beem.2024.101958_bib11","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1097\/PAP.0000000000000365","article-title":"Advances in adrenal and extra-adrenal paraganglioma: practical synopsis for pathologists","volume":"30","author":"Juhlin","year":"2023","journal-title":"Adv Anat Pathol"},{"issue":"3","key":"10.1016\/j.beem.2024.101958_bib12","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1038\/s41574-023-00926-0","article-title":"Management of phaeochromocytoma and paraganglioma in patients with germline SDHB pathogenic variants: an international expert Consensus statement","volume":"20","author":"Ta\u00efeb","year":"2024","journal-title":"Nat Rev Endocrinol"},{"key":"10.1016\/j.beem.2024.101958_bib13","doi-asserted-by":"crossref","DOI":"10.1016\/j.beem.2024.101938","article-title":"Overview of recent guidelines and consensus statements on initial screening and management of phaeochromocytoma and paraganglioma in SDHx pathogenic variant carriers and patients","author":"Lussey-Lepoutre","year":"2024","journal-title":"Best Pr Res Clin Endocrinol Metab"},{"issue":"2","key":"10.1016\/j.beem.2024.101958_bib14","doi-asserted-by":"crossref","first-page":"182","DOI":"10.5858\/arpa.2012-0551-OA","article-title":"Protocol for the examination of specimens from patients with pheochromocytomas and extra-adrenal paragangliomas","volume":"138","author":"Mete","year":"2014","journal-title":"Arch Pathol Lab Med"},{"key":"10.1016\/j.beem.2024.101958_bib15","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.humpath.2020.04.012","article-title":"Data set for the reporting of pheochromocytoma and paraganglioma: explanations and recommendations of the guidelines from the International Collaboration on Cancer Reporting","volume":"110","author":"Thompson","year":"2021","journal-title":"Hum Pathol"},{"issue":"9","key":"10.1016\/j.beem.2024.101958_bib16","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1097\/PAS.0000000000001715","article-title":"Significance of alpha-inhibin expression in pheochromocytomas and paragangliomas","volume":"45","author":"Mete","year":"2021","journal-title":"Am J Surg Pathol"},{"issue":"1","key":"10.1016\/j.beem.2024.101958_bib17","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1007\/s12022-020-09658-7","article-title":"What have we learned from molecular biology of paragangliomas and pheochromocytomas?","volume":"32","author":"Papathomas","year":"2021","journal-title":"Endocr Pathol"},{"issue":"1","key":"10.1016\/j.beem.2024.101958_bib18","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1007\/s12022-022-09703-7","article-title":"Overview of the 2022 WHO classification of pituitary tumors","volume":"33","author":"Asa","year":"2022","journal-title":"Endocr Pathol"},{"key":"10.1016\/j.beem.2024.101958_bib19","doi-asserted-by":"crossref","DOI":"10.7326\/aimcc.2023.0361","article-title":"Succinate dehydrogenase\u2013deficient paraganglioma of the prostate","volume":"2","author":"Szuman","year":"2023","journal-title":"AIM Clin Cases"},{"issue":"3","key":"10.1016\/j.beem.2024.101958_bib20","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1007\/s12022-013-9296-1","article-title":"Functional cardiac paraganglioma associated with a rare SDHC mutation","volume":"25","author":"Millar","year":"2014","journal-title":"Endocr Pathol"},{"key":"10.1016\/j.beem.2024.101958_bib21","doi-asserted-by":"crossref","DOI":"10.1016\/j.mce.2020.110998","article-title":"Stem cells, evolutionary aspects and pathology of the adrenal medulla: A new developmental paradigm","volume":"518","author":"Kastriti","year":"2020","journal-title":"Mol Cell Endocrinol"},{"key":"10.1016\/j.beem.2024.101958_bib22","doi-asserted-by":"crossref","first-page":"6","DOI":"10.3389\/fnmol.2019.00006","article-title":"Schwann cell precursors generate the majority of chromaffin cells in Zuckerkandl organ and some sympathetic neurons in paraganglia","volume":"12","author":"Kastriti","year":"2019","journal-title":"Front Mol Neurosci"},{"key":"10.1016\/j.beem.2024.101958_bib23","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1007\/s12022-017-9494-3","article-title":"Composite pheochromocytoma\/paraganglioma-ganglioneuroma: a clinicopathologic study of eight cases with analysis of succinate dehydrogenase","volume":"28","author":"Gupta","year":"2017","journal-title":"Endocr Pathol"},{"key":"10.1016\/j.beem.2024.101958_bib24","doi-asserted-by":"crossref","first-page":"e91","DOI":"10.4158\/EP11370.CR","article-title":"Pheochromocytoma with histologic transformation to composite type, complicated by watery diarrhea, hypokalemia, and achlorhydria syndrome","volume":"18","author":"Kikuchi","year":"2012","journal-title":"Endocr Pr"},{"key":"10.1016\/j.beem.2024.101958_bib25","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1055\/s-0031-1299111","article-title":"A 45-year-old female with hypokalemic rhabdomyolysis due to VIP-producing composite pheochromocytoma","volume":"50","author":"Ende","year":"2012","journal-title":"Z Gastroenterol"},{"key":"10.1016\/j.beem.2024.101958_bib26","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1097\/MEG.0b013e328311a697","article-title":"Composite adrenal phaeochromocytoma-ganglioneuroma causing watery diarrhoea, hypokalaemia and achlorhydria syndrome","volume":"22","author":"George","year":"2010","journal-title":"Eur J Gastroenterol Hepatol"},{"issue":"2","key":"10.1016\/j.beem.2024.101958_bib27","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1002\/(SICI)1097-0142(19990715)86:2<349::AID-CNCR20>3.0.CO;2-Y","article-title":"Terminology and morphologic criteria of neuroblastic tumors: recommendations by the International Neuroblastoma Pathology Committee","volume":"86","author":"Shimada","year":"1999","journal-title":"Cancer"},{"issue":"6","key":"10.1016\/j.beem.2024.101958_bib28","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1007\/s00401-020-02218-7","article-title":"Molecular characterization of CNS paragangliomas identifies cauda equina paragangliomas as a distinct tumor entity","volume":"140","author":"Schweizer","year":"2020","journal-title":"Acta Neuropathol"},{"key":"10.1016\/j.beem.2024.101958_bib29","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1007\/s00401-020-02221-y","article-title":"The immunohistochemical, DNA methylation, and chromosomal copy number profile of cauda equina paraganglioma is distinct from extra-spinal paraganglioma","volume":"140","author":"Ramani","year":"2020","journal-title":"Acta Neuropathol"},{"issue":"4","key":"10.1016\/j.beem.2024.101958_bib30","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1097\/PAS.0000000000002009","article-title":"Cauda equina neuroendocrine tumors: distinct epithelial neuroendocrine neoplasms of spinal origin","volume":"47","author":"Asa","year":"2023","journal-title":"Am J Surg Pathol"},{"issue":"3","key":"10.1016\/j.beem.2024.101958_bib31","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1007\/s12022-013-9258-7","article-title":"Endobronchial gangliocytic paraganglioma: not all keratin-positive endobronchial neuroendocrine neoplasms are pulmonary carcinoids","volume":"25","author":"Gucer","year":"2014","journal-title":"Endocr Pathol"},{"key":"10.1016\/j.beem.2024.101958_bib32","doi-asserted-by":"crossref","DOI":"10.1007\/s12022-024-09840-1","article-title":"Cauda equina neuroendocrine tumors with ganglioneuromatous elements are best classified as Composite Gangliocytoma\/neuroma and Neuroendocrine Tumor (COGNET)","author":"Dogukan","year":"2024","journal-title":"Endocr Pathol"},{"issue":"5","key":"10.1016\/j.beem.2024.101958_bib33","first-page":"246","article-title":"Familial endocrine tumor syndromes: clinical and predictive roles of molecular histopathology","volume":"22","author":"Duan","year":"2017","journal-title":"AJSP: Rev Rep"},{"key":"10.1016\/j.beem.2024.101958_bib34","doi-asserted-by":"crossref","unstructured":"Mete O., Hannah-Shmouni F., Kim R., Stratakis C.A. Inherited neuroendocrine neoplasms. In: Asa SL, La Rosa S, Mete O (eds). The spectrum of neuroendocrine neoplasia. Springer, Cham, pp: 409\u2013459.","DOI":"10.1007\/978-3-030-54391-4_18"},{"key":"10.1016\/j.beem.2024.101958_bib35","doi-asserted-by":"crossref","first-page":"1518","DOI":"10.1210\/js.2019-00200","article-title":"Presentation, treatment, histology, and outcomes in adrenal medullary hyperplasia compared with pheochromocytoma","volume":"3","author":"Falhammar","year":"2019","journal-title":"J Endocr Soc"},{"key":"10.1016\/j.beem.2024.101958_bib36","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1007\/s12022-016-9460-5","article-title":"Pathological and genetic characterization of bilateral adrenomedullary hyperplasia in a patient with germline MAX mutation","volume":"28","author":"Romanet","year":"2017","journal-title":"Endocr Pathol"},{"key":"10.1016\/j.beem.2024.101958_bib37","doi-asserted-by":"crossref","first-page":"e200","DOI":"10.1200\/JCO.2010.32.2156","article-title":"Bilateral adrenal medullary hyperplasia associated with an SDHB mutation","volume":"29","author":"Grogan","year":"2011","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.beem.2024.101958_bib38","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1007\/s00428-015-1755-2","article-title":"Familial pheochromocytoma and renal cell carcinoma syndrome: TMEM127 as a novel candidate gene for the association","volume":"466","author":"Hernandez","year":"2015","journal-title":"Virchows Arch"},{"key":"10.1016\/j.beem.2024.101958_bib39","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1210\/clinem\/dgaa957","article-title":"Multiple endocrine tumors associated with germline MAX mutations: multiple endocrine neoplasia type 5?","volume":"106","author":"Seabrook","year":"2021","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"10.1016\/j.beem.2024.101958_bib40","first-page":"243","volume":"53","author":"Rizzo","year":"2001","journal-title":"Chir Ital"},{"key":"10.1016\/j.beem.2024.101958_bib41","doi-asserted-by":"crossref","first-page":"234","DOI":"10.3389\/fendo.2020.00234","article-title":"A novel MAX gene mutation variant in a patient with multiple and \"composite\" neuroendocrine-neuroblastic tumors","volume":"11","author":"Pozza","year":"2020","journal-title":"Front Endocrinol"},{"issue":"2","key":"10.1016\/j.beem.2024.101958_bib42","doi-asserted-by":"crossref","first-page":"263","DOI":"10.5858\/arpa.2013-0520-RS","article-title":"Endocrine manifestations of von Hippel-Lindau disease","volume":"139","author":"Cassol","year":"2015","journal-title":"Arch Pathol Lab Med"},{"issue":"1","key":"10.1016\/j.beem.2024.101958_bib43","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1385\/EP:13:1:17","article-title":"Pheochromocytoma in von hippel-lindau disease: distinct histopathologic phenotype compared to pheochromocytoma in multiple endocrine neoplasia type 2","volume":"13","author":"Koch","year":"2002","journal-title":"Endocr Pathol"},{"issue":"4","key":"10.1016\/j.beem.2024.101958_bib44","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1007\/s12022-022-09730-4","article-title":"K. PHOX2B is a sensitive and specific marker for the histopathological diagnosis of pheochromocytoma and paraganglioma","volume":"33","author":"Miyauchi","year":"2022","journal-title":"Endocr Pathol"},{"issue":"2","key":"10.1016\/j.beem.2024.101958_bib45","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1007\/s12022-020-09618-1","article-title":"The diagnostic dilemma of GATA3 immunohistochemistry in pheochromocytoma and paraganglioma","volume":"31","author":"Kimura","year":"2020","journal-title":"Endocr Pathol"},{"issue":"1","key":"10.1016\/j.beem.2024.101958_bib46","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1007\/s12022-024-09803-6","article-title":"Hand2 immunohistochemistry in the diagnosis of paragangliomas and other neuroendocrine neoplasms","volume":"35","author":"Soukup","year":"2024","journal-title":"Endocr Pathol"},{"issue":"4","key":"10.1016\/j.beem.2024.101958_bib47","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1007\/s12022-021-09694-x","article-title":"Immunohistochemical expression of choline acetyltransferase and catecholamine-synthesizing enzymes in head-and-neck and thoracoabdominal paragangliomas and pheochromocytomas","volume":"32","author":"Kimura","year":"2021","journal-title":"Endocr Pathol"},{"key":"10.1016\/j.beem.2024.101958_bib48","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1093\/ajcp\/102.2.163","article-title":"Immunohistochemical detection of neuroblastomatous foci in composite adrenal pheochromocytoma-neuroblastoma","volume":"102","author":"Franquemont","year":"1994","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.beem.2024.101958_bib49","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1007\/s12022-020-09633-2","article-title":"Immunohistochemical staining for SOX10 and SDHB in SDH-deficient paragangliomas indicates that sustentacular cells are not neoplastic","volume":"31","author":"Powers","year":"2020","journal-title":"Endocr Pathol"},{"key":"10.1016\/j.beem.2024.101958_bib50","doi-asserted-by":"crossref","first-page":"2382","DOI":"10.1210\/me.2010-0256","article-title":"Research resource: transcriptional profiling reveals different pseudohypoxic signatures in SDHB and VHL-related pheochromocytomas","volume":"24","author":"L\u00f3pez-Jim\u00e9nez","year":"2010","journal-title":"Mol Endocrinol"},{"key":"10.1016\/j.beem.2024.101958_bib51","doi-asserted-by":"crossref","first-page":"2440","DOI":"10.1093\/hmg\/ddt639","article-title":"Germline mutations in FH confer predisposition to malignant pheochromocytomas and paragangliomas","volume":"23","author":"Castro-Vega","year":"2014","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.beem.2024.101958_bib52","doi-asserted-by":"crossref","first-page":"djv053","DOI":"10.1093\/jnci\/djv053","article-title":"Whole-exome sequencing identifies MDH2 as a new familial paraganglioma gene","volume":"107","author":"Casc\u00f3n","year":"2015","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.beem.2024.101958_bib53","doi-asserted-by":"crossref","first-page":"2169","DOI":"10.1093\/hmg\/ddt069","article-title":"Tumoral EPAS1 (HIF2A) mutations explain sporadic pheochromocytoma and paraganglioma in the absence of erythrocytosis","volume":"22","author":"Comino-M\u00e9ndez","year":"2013","journal-title":"Hum Mol Gene"},{"key":"10.1016\/j.beem.2024.101958_bib54","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1007\/s00109-014-1205-7","article-title":"Germ-line PHD1 and PHD2 mutations detected in patients with pheochromocytoma\/paraganglioma-polycythemia","volume":"93","author":"Yang","year":"2015","journal-title":"J Mol Med (Berl)"},{"key":"10.1016\/j.beem.2024.101958_bib55","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1530\/ERC-19-0024","article-title":"Genotype-phenotype correlations in pheochromocytoma and paraganglioma: a systematic review and individual patient meta-analysis","volume":"26","author":"Crona","year":"2019","journal-title":"Endocr Relat Cancer"},{"key":"10.1016\/j.beem.2024.101958_bib56","doi-asserted-by":"crossref","DOI":"10.1016\/j.beem.2024.101931","article-title":"MAML3-fusions modulate vascular and immune tumour microenvironment and confer high metastatic risk in pheochromocytoma and paraganglioma","author":"Monteagudo","year":"2024","journal-title":"Best Pr Res Clin Endocrinol Metab"},{"key":"10.1016\/j.beem.2024.101958_bib57","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1038\/modpathol.2015.41","article-title":"SDHB\/SDHA immunohistochemistry in pheochromocytomas and paragangliomas: a multicenter interobserver variation analysis using virtual microscopy: a Multinational Study of the European Network for the Study of Adrenal Tumors (ENS@T)","volume":"28","author":"Papathomas","year":"2015","journal-title":"Mod Pathol"},{"key":"10.1016\/j.beem.2024.101958_bib58","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1038\/s41379-019-0343-4","article-title":"Carbonic anhydrase 9 immunohistochemistry as a tool to predict or validate germline and somatic VHL mutations in pheochromocytoma and paraganglioma-a retrospective and prospective study","volume":"33","author":"Favier","year":"2020","journal-title":"Mod Pathol"},{"key":"10.1016\/j.beem.2024.101958_bib59","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1097\/00000478-200205000-00002","article-title":"Pheochromocytoma of the Adrenal gland Scaled Score (PASS) to separate benign from malignant neoplasms: a clinicopathologic and immunophenotypic study of 100 cases","volume":"26","author":"Thompson","year":"2002","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.beem.2024.101958_bib60","doi-asserted-by":"crossref","first-page":"e4661","DOI":"10.1210\/clinem\/dgaa608","article-title":"Predicting metastatic potential in pheochromocytoma and paraganglioma: a comparison of PASS and GAPP scoring systems","volume":"105","author":"Wachtel","year":"2020","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.beem.2024.101958_bib61","doi-asserted-by":"crossref","first-page":"225","DOI":"10.3390\/cancers11020225","article-title":"The value of histological algorithms to predict the malignancy potential of pheochromocytomas and abdominal paragangliomas \u2013 a meta-analysis and systematic review of the literature","volume":"11","author":"Stenman","year":"2019","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.beem.2024.101958_bib62","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1530\/ERC-13-0494","article-title":"Pathological grading for predicting metastasis in phaeochromocytoma and paraganglioma","volume":"21","author":"Kimura","year":"2014","journal-title":"Endocr Relat Cancer"},{"key":"10.1016\/j.beem.2024.101958_bib63","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1002\/(SICI)1097-0142(19991015)86:8<1583::AID-CNCR28>3.0.CO;2-#","article-title":"Predicting metastasis of pheochromocytomas using DNA flow cytometry and immunohistochemical markers of cell proliferation: a positive correlation between MIB-1 staining and malignant tumor behavior","volume":"86","author":"Brown","year":"1999","journal-title":"Cancer"},{"key":"10.1016\/j.beem.2024.101958_bib64","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1007\/s12022-022-09746-w","article-title":"TOP2A expression in pheochromocytoma and abdominal paraganglioma: a marker of poor clinical outcome?","volume":"34","author":"Solhusl\u00f8kk H\u00f6se","year":"2023","journal-title":"Endocr Pathol"},{"key":"10.1016\/j.beem.2024.101958_bib65","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1097\/PAS.0000000000001190","article-title":"Molecular profiling of pheochromocytoma and abdominal paraganglioma stratified by the PASS algorithm reveals Chromogranin B as associated with histologic prediction of malignant behavior","volume":"43","author":"Stenman","year":"2019","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.beem.2024.101958_bib66","doi-asserted-by":"crossref","first-page":"6140","DOI":"10.1038\/ncomms7140","article-title":"Whole-exome sequencing identifies somatic ATRX mutations in pheochromocytomas and paragangliomas","volume":"6","author":"Fishbein","year":"2015","journal-title":"Nat Commun"},{"key":"10.1016\/j.beem.2024.101958_bib67","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1007\/s12020-022-03218-1","article-title":"Immune signature of pheochromocytoma and paraganglioma in context of neuroendocrine neoplasms associated with prognosis","volume":"79","author":"Ghosal","year":"2023","journal-title":"Endocrine"}],"container-title":["Best Practice &amp; Research Clinical Endocrinology &amp; Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521690X24001349?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521690X24001349?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,19]],"date-time":"2025-01-19T18:01:26Z","timestamp":1737309686000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1521690X24001349"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12]]},"references-count":67,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2024,12]]}},"alternative-id":["S1521690X24001349"],"URL":"https:\/\/doi.org\/10.1016\/j.beem.2024.101958","relation":{},"ISSN":["1521-690X"],"issn-type":[{"value":"1521-690X","type":"print"}],"subject":[],"published":{"date-parts":[[2024,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Recent progress in the pathologic classification of pheochromocytomas and paragangliomas","name":"articletitle","label":"Article Title"},{"value":"Best Practice & Research Clinical Endocrinology & Metabolism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.beem.2024.101958","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"101958"}}